الملاحظات

Member for: 3 days (since Jul 5)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/shp099-dihydrochloride.html
About: The period Two study involving day-to-day carboplatin plus irradiation as well as durvalumab pertaining to point III non-small cellular lung cancer patients along with P . s . Two as much as 74 years old along with sufferers with P . s . 0 as well as 1 via 75 years: NEJ039A (tryout in progress).

Activity by statecamp1

Score: 0 points
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

3.3k questions

10.4k answers

14.1k comments

2.7m users

مرحبًا بك إلى Zamericanenglish Q&A، حيث يمكنك طرح الأسئلة وانتظار الإجابة عليها من المستخدمين الآخرين.
add
...